Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Automation with Air: Analytical Sample Management Solution Showcased at Pittcon

Published: Thursday, March 14, 2013
Last Updated: Thursday, March 14, 2013
Bookmark and Share
TTP Labtech’s lab2lab connects remote analytical labs.

TTP Labtech will be attending the Pittcon conference and exposition this year, 17th - 21st March, Philadelphia PA, showcasing the lab2lab automated sample transport and management system, on booth 558.

TTP Labtech’s lab2lab innovatively connects remote analytical instrumentation and research laboratories by transporting tubes using compressed air.

The system effectively ensures that samples are scheduled and analyzed at the right time, in the right place, helping to send samples to the shortest queue.

The results are then returned via the network to the scientist’s electronic lab notebook to generate data even faster.

The huge capital cost and maintenance overheads associated with analytical instrumentation such as LC-MS makes it unfeasible to have in every medicinal lab.

With TTP Labtech’s lab2lab, existing centralized analytical instrumentation can be connected with several remote labs, thereby ensuring access to the analysis at a much lower cost.

Christopher Howson BSc (Hons) MRSC, from Novartis Institutes for Biomedical Research, will be giving a presentation on “Satisfying the Analytical Needs of Scientists in the Most Efficient Way”.

The presentation will cover a case study of lab2lab within the Horsham sector of Novartis Global Discovery Chemistry and discuss the particular importance for medicinal chemists of having easy and instant access to analytical instruments located in distant laboratories.

The successful integration of TTP Labtech’s lab2lab allows samples to be sent direct from the bench tops to analytical equipment, allowing the medicinal chemist to focus on their research rather than waiting for their samples to be analyzed.

During the exhibition, TTP Labtech will also be running a lab2lab tube competition at their booth (#558) where a lucky registrant will win an iPad mini.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos